Radioguided Reoperative Thyroid and Parathyroid Surgery

Otolaryngologic Clinics of North America

Volumn 41, Issue 6, 2008, Pages 1185-1198

  Ondik, Michael P ^a   Tulchinsky, Mark ^a   Goldenberg, David ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; HEXOKINASE; INDIUM 111; IODINE 123; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MONOCLONAL ANTIBODY IN 111; PARATHYROID HORMONE; PENTETREOTIDE IN 111; RADIOPHARMACEUTICAL AGENT; SODIUM IODIDE I 131; SOMATOSTATIN RECEPTOR; SUCCIMER TC 99M; TRACER;

ARTICLE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG UPTAKE; ENDOCRINE SURGERY; FOLLICULAR CARCINOMA; HISTOPATHOLOGY; HUMAN; IODINE 131 UPTAKE TEST; MINIMALLY INVASIVE RADIOGUIDED PARATHYROIDECTOMY; MINIMALLY INVASIVE SURGERY; PARATHYROID DISEASE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; RADIATION DOSE; RADIOGUIDED REOPERATIVE PARATHYROID SURGERY; RADIOGUIDED REOPERATIVE THYROID SURGERY; REOPERATION; SECONDARY HYPERPARATHYROIDISM; THYROID CANCER; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID SCINTISCANNING; THYROID SURGERY; THYROIDECTOMY; TREATMENT INDICATION;

DIAGNOSTIC IMAGING; HUMANS; INTRAOPERATIVE PERIOD; PARATHYROID DISEASES; RADIOPHARMACEUTICALS; REOPERATION; SURGERY, COMPUTER-ASSISTED; TECHNETIUM TC 99M SESTAMIBI; THYROID DISEASES; THYROID NEOPLASMS;

EID: 56449085936     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2008.07.002     Document Type: Article

References (67)

1. Gulec S.A., Eckert M., and Woltering E.A. Gamma probe-guided lymph node dissection ('gamma picking') in differentiated thyroid carcinoma. Clin Nucl Med 27 12 (2002) 859-861
2. Elser H., Henze M., Hermann C., et al. [99m-Tc-MIBI for recurrent and metastatic differentiated thyroid carcinoma]. Nuklearmedizin 36 1 (1997) 7-12 [German]
3. Franceschi M., Kusic Z., Franceschi D., et al. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 37 3 (1996) 446-451
4. Rubello D., Mazzarotto R., and Casara D. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery. Eur J Nucl Med 27 4 (2000) 431-440
5. Yen T.C., Lin H.D., Lee C.H., et al. The role of technetium-99m sestamibi whole-body scans in diagnosing metastatic Hurthle cell carcinoma of the thyroid gland after total thyroidectomy: a comparison with iodine-131 and thallium-201 whole-body scans. Eur J Nucl Med 21 9 (1994) 980-983
6. Pedersen M.W., Holm S., Lund E.L., et al. Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro. Neoplasia 3 1 (2001) 80-87
7. Bos R., van Der Hoeven J.J., van Der Wall E., et al. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol 20 2 (2002) 379-387
8. Zhao S., Kuge Y., Mochizuki T., et al. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med 46 4 (2005) 675-682
9. Hooft L., van der Veldt A.A., van Diest P.J., et al. [18F]fluorodeoxyglucose uptake in recurrent thyroid cancer is related to hexokinase I expression in the primary tumor. J Clin Endocrinol Metab 90 1 (2005) 328-334
10. Adams S., Baum R.P., Hertel A., et al. Intraoperative gamma probe detection of neuroendocrine tumors. J Nucl Med 39 7 (1998) 1155-1160
11. Juweid M., Sharkey R.M., Behr T., et al. Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies. J Nucl Med 37 6 (1996) 905-911
12. Le Doussal J.M., Gruaz-Guyon A., Martin M., et al. Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice. Cancer Res 50 11 (1990) 3445-3452
13. O'Byrne K.J., Hamilton D., Robinson I., et al. Imaging of medullary carcinoma of the thyroid using 111In-labelled anti-CEA monoclonal antibody fragments. Nucl Med Commun 13 3 (1992) 142-148
14. Peltier P., Curtet C., Chatal J.F., et al. Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. J Nucl Med 34 8 (1993) 1267-1273
15. Harris C.C., Bigelow R.R., Francis J.E., et al. A CsI(T1)-crystal scintillation probe. Nucleonics 14 (1956) 104-108
16. Moffat Jr. F.L. Targeting gold at the end of the rainbow: surgical gamma probes in the 21st century. J Surg Oncol 96 4 (2007) 286-289
17. Curtet C., Carlier T., Mirallie E., et al. Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence. Eur J Nucl Med Mol Imaging 34 10 (2007) 1556-1562
18. Gulec S.A., Hoenie E., Hostetter R., et al. PET probe-guided surgery: applications and clinical protocol. World J Surg Oncol 5 (2007) 65
19. Kraeber-Bodere F., Cariou B., Curtet C., et al. Feasibility and benefit of fluorine 18-fluoro-2-deoxyglucose-guided surgery in the management of radioiodine-negative differentiated thyroid carcinoma metastases. Surgery 138 6 (2005) 1176-1182 [discussion: 1182]
20. Piert M., Carey J., and Clinthorne N. Probe-guided localization of cancer deposits using [18F]fluorodeoxyglucose. Q J Nucl Med Mol Imaging 52 1 (2008) 37-49
21. Ortega J., Ferrer-Rebolleda J., Cassinello N., et al. Potential role of a new hand-held miniature gamma camera in performing minimally invasive parathyroidectomy. Eur J Nucl Med Mol Imaging 34 2 (2007) 165-169
22. Scurry W.C., Lamarre E., and Stack B. Radioguided neck dissection in recurrent metastatic papillary thyroid carcinoma. Am J Otolaryngol 27 1 (2006) 61-63
23. Gallowitsch H.J., Fellinger J., Mikosch P., et al. Gamma probe-guided resection of a lymph node metastasis with I-123 in papillary thyroid carcinoma. Clin Nucl Med 22 9 (1997) 591-592
24. 131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab 83 8 (1998) 2675-2680
25. Salvatori M., Rufini V., Reale F., et al. Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer. World J Surg 27 7 (2003) 770-775
26. Salvatori M., Ardito G., Pelizzo M.R., et al. Treatment of local and regional recurrences of differentiated thyroid cancer by radio-guided surgery with iodine-131. Nucl Med Rev Cent East Eur 9 2 (2006) 119-124
27. Rubello D., Salvatori M., Ardito G., et al. Iodine-131 radio-guided surgery in differentiated thyroid cancer: outcome on 31 patients and review of the literature. Biomed Pharmacother 61 8 (2007) 477-481
28. Voutilainen P.E., Multanen M.M., Leppaniemi A.K., et al. Prognosis after lymph node recurrence in papillary thyroid carcinoma depends on age. Thyroid 11 10 (2001) 953-957
29. Rouxel A., Hejblum G., Bernier M.O., et al. Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas. J Clin Endocrinol Metab 89 11 (2004) 5362-5368
30. Boz A., Arici C., Gungor F., et al. Gamma probe-guided resection and scanning with Tc-99m MIBI of a local recurrence of follicular thyroid carcinoma. Clin Nucl Med 26 10 (2001) 820-822
31. Rubello D., Piotto A., Pagetta C., et al. (99m)Tc-MIBI radio-guided surgery for recurrent thyroid carcinoma: technical feasibility and procedure, and preliminary clinical results. Eur J Nucl Med Mol Imaging 29 9 (2002) 1201-1205
32. Rubello D., Fig L.M., Casara D., et al. Radioguided surgery of parathyroid adenomas and recurrent thyroid cancer using the "low sestamibi dose" protocol. Cancer Biother Radiopharm 21 3 (2006) 194-205
33. 131Iodine-negative recurrent thyroid cancer. Eur J Surg Oncol 33 7 (2007) 902-906
34. Essner R., Hsueh E.C., Haigh P.I., et al. Application of an [(18)F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy. J Surg Res 96 1 (2001) 120-126
35. Zervos E.E., Desai D.C., DePalatis L.R., et al. 18F-labeled fluorodeoxyglucose positron emission tomography-guided surgery for recurrent colorectal cancer: a feasibility study. J Surg Res 97 1 (2001) 9-13
36. Barbet J., Peltier P., Bardet S., et al. Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody. J Nucl Med 39 7 (1998) 1172-1178
37. de Labriolle-Vaylet C., Cattan P., Sarfati E., et al. Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguided surgery. Clin Cancer Res 6 2 (2000) 363-371
38. Waddington W.A., Kettle A.G., Heddle R.M., et al. Intraoperative localization of recurrent medullary carcinoma of the thyroid using indium-111 pentetreotide and a nuclear surgical probe. Eur J Nucl Med 21 4 (1994) 363-364
39. Adams S., Acker P., Lorenz M., et al. Radioisotope-guided surgery in patients with pheochromocytoma and recurrent medullary thyroid carcinoma: a comparison of preoperative and intraoperative tumor localization with histopathologic findings. Cancer 92 2 (2001) 263-270
40. Guerra U.P., Pizzocaro C., Terzi A., et al. New tracers for the imaging of the medullary thyroid carcinoma. Nucl Med Commun 10 4 (1989) 285-295
41. Thomas C.C., Cowan R.J., Albertson D.A., et al. Detection of medullary carcinoma of the thyroid with I-131 MIBG. Clin Nucl Med 19 12 (1994) 1066-1068
42. Shimotake T., Tsuda T., Aoi S., et al. Iodine 123 metaiodobenzylguanidine radio-guided navigation surgery for recurrent medullary thyroid carcinoma in a girl with multiple endocrine neoplasia type 2B. J Pediatr Surg 40 10 (2005) 1643-1646
43. Negele T., Meisetschlager G., Bruckner T., et al. Radio-guided surgery for persistent differentiated papillary thyroid cancer: case presentations and review of the literature. Langenbecks Arch Surg 391 3 (2006) 178-186
44. Reubi J.C., Krenning E., Lamberts S.W., et al. In vitro detection of somatostatin receptors in human tumors. Digestion 54 Suppl 1 (1993) 76-83
45. Kwekkeboom D.J., Reubi J.C., Lamberts S.W., et al. In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J Clin Endocrinol Metab 76 6 (1993) 1413-1417
46. Tukenmez M., Erbil Y., Barbaros U., et al. Radio-guided nonpalpable metastatic lymph node localization in patients with recurrent thyroid cancer. J Surg Oncol 96 6 (2007) 534-538
47. Mandl F. Richtlinien für die Praxis: Die Behandlung der lokali-sierten und generalisierten Ostitis fibrosa. Wiener Klinische Wochenschrift 39 37 (1926) 1046-1048
48. Tibblin S., Bondeson A.G., and Ljungberg O. Unilateral parathyroidectomy in hyperparathyroidism due to single adenoma. Ann Surg 195 3 (1982) 245-252
49. Martinez D.A., King D.R., Romshe C., et al. Intraoperative identification of parathyroid gland pathology: a new approach. J Pediatr Surg 30 9 (1995) 1306-1309
50. Norman J., and Chheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery 122 6 (1997) 998-1003 [discussion: 1003-4]
51. Taillefer R., Boucher Y., Potvin C., et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 33 10 (1992) 1801-1807
52. Vassy W.M., Nelson Jr. H.S., Mancini M.L., et al. Minimally invasive parathyroidectomy: how effective is preoperative sestamibi scanning?. Am Surg 69 12 (2003) 1090-1094
53. Norman J., Chheda H., and Farrell C. Minimally invasive parathyroidectomy for primary hyperparathyroidism: decreasing operative time and potential complications while improving cosmetic results. Am Surg 64 5 (1998) 391-395 [discussion: 395-6]
54. Rubello D., Giannini S., Martini C., et al. Minimally invasive radio-guided parathyroidectomy. Biomed Pharmacother 60 3 (2006) 134-138
55. Ruda J.M., Hollenbeak C.S., and Stack Jr. B.C. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 132 3 (2005) 359-372
56. Norman J., and Denham D. Minimally invasive radioguided parathyroidectomy in the reoperative neck. Surgery 124 6 (1998) 1088-1092 [discussion: 1092-3]
57. Damrose E.J., Hoh C., and Calcaterra T.C. Gamma-probe localization of a parathyroid adenoma in the reoperative neck. Am J Otolaryngol 21 6 (2000) 394-397
58. Hung G.U., Wu H.S., Tsai S.C., et al. Recurrent hyperfunctioning parathyroid gland demonstrated on radionuclide imaging and an intraoperative gamma probe. Clin Nucl Med 25 5 (2000) 348-350
59. Navarra G., Ascanelli S., Feggi L., et al. Radio-guided surgery in recurrent renal hyperparathyroidism: report of a case. Head Neck 22 6 (2000) 618-620
60. Placzkowski K., Christian R., and Chen H. Radioguided parathyroidectomy for recurrent parathyroid cancer. Clin Nucl Med 32 5 (2007) 358-360
61. 99mTc-sestamibi protocol'. Nucl Med Commun 27 9 (2006) 709-713
62. Friedman M., Gurpinar B., Schalch P., et al. Guidelines for radioguided parathyroid surgery. Arch Otolaryngol Head Neck Surg 133 12 (2007) 1235-1239
63. 99mTc-sestamibi subtraction single photon emission computed tomography. J Clin Endocrinol Metab 83 11 (1998) 3867-3871
64. Pattou F., Huglo D., and Proye C. Radionuclide scanning in parathyroid diseases. Br J Surg 85 12 (1998) 1605-1616
65. Piga M., Bolasco P., Satta L., et al. Double phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism. J Nucl Med 37 4 (1996) 565-569
66. Lal A., and Chen H. The negative sestamibi scan: is a minimally invasive parathyroidectomy still possible?. Ann Surg Oncol 14 8 (2007) 2363-2366
67. 99mTc-sestamibi. Nucl Med Commun 27 1 (2006) 1-4